About MATRISOME BIO, INC.
Matrisome Bio is a seed-stage start-up pioneering targeted therapies that deliver potent payloads directly to the extracellular matrix (ECM) of tumors and metastases, offering unmatched precision and therapeutic index. The company focuses on developing a multi-modality platform for effective treatment of solid tumors and chronic diseases.
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| NOVEL THERANOSTIC RADIOLIGANDS TARGETING DISEASE-SPECIFIC EXTRACELLULAR MATRIX COMPONENTS SPECIFIC TO TUMOR AN | Department of Health and Human Services | $354K |
Is this your company?
Claim MATRISOME BIO, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim MATRISOME BIO, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.